Accessibility Menu
Reflect Scientific logo

Reflect Scientific(OTC) RSCF

Market Cap$4.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)-95%
5 Year-87%
1 Year-30%
1 Month+22%
$0.05
+5.96%
+0.00Today
Reflect Scientific last closing stock price
MetricPriceDate
Last closeUSD 0.052026-08-17
Reflect Scientific stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+28.91%USD 0.042026-08-10
1 month+22.11%USD 0.042026-07-16
3 month+19.9%USD 0.042026-05-18
Year to date-5.76%USD 0.052025-12-31
1 year-30.21%USD 0.072025-08-15
3 year-36.85%USD 0.082023-08-18
5 year-86.73%USD 0.382021-08-18
Since inception-95.02%USD 1.002005-07-07

Reflect Scientific Financials at a Glance

Market Cap

$4.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.78M

Net Income (TTM)

$322.04K

EPS (TTM)

$0.00

P/E Ratio

13.09

Dividend

$0.00

Beta (Volatility)

0.34 (Low)

Price

$0.05

Volume

16,200

Open

$0.05

Previous Close

$0.05

Daily Range

$0.05 - $0.05

52-Week Range

$0.02 - $0.07

Estimated Earnings Date

Nov 10, 2025

RSCF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Reflect Scientific

Reflect Scientific, Inc. specializes in the design, development, and sale of scientific equipment for the life science and manufacturing industries. The company offers a range of products, including ultra-low temperature freezers and laboratory consumables, serving various sectors such as hospitals, pharmaceutical companies, and research facilities.

Products and Services
  • Cryometrix ultra-low temperature and blast freezers for product storage
  • Laboratory consumables including filtration and purification products
  • Refrigerated transportation products and UV detectors
Growth Outlook
  • Recent quarterly revenue of $393,442 shows a strong recovery trend
  • Trailing twelve months (TTM) gross profit margin stands at 33.77%
  • Current ratio of 8.14 indicates strong liquidity and operational efficiency
Financial Highlights
  • Net income for Q1 2026 reached $69,634, reflecting operational profitability
  • TTM price-to-earnings ratio of 15 suggests reasonable valuation
  • Cash and cash equivalents totaled $1,643,996, ensuring financial stability
Reflect Scientific, Inc. operates in a niche market with a focus on high-demand scientific equipment. The company's diverse product offerings cater to essential sectors, positioning it well for future growth. Recent financial performance indicates a positive trajectory, with increasing revenues and a solid liquidity position. The strong gross profit margin and net income reflect effective cost management and operational efficiency. Overall, Reflect Scientific presents an intriguing opportunity for investors interested in the healthcare and scientific equipment sectors.
AI Generated • Aug 7, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

6

CEO

Kim Boyce

Website

www.reflectscientific.com

Headquarters

Orem, UT 84058, US

RSCF Financials

Key Financial Metrics (TTM)

Gross Margin

31.09%

Operating Margin

15.18%

Net Income Margin

18.14%

Return on Equity

14.00%

Return on Capital

7.02%

Return on Assets

12.17%

Earnings Yield

7.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

85.66M

Volume

16.20K

Avg. Volume

50.04K

Financials (TTM)

Gross Profit

$551.97K

Operating Income

$269.46K

EBITDA

$365.95K

Operating Cash Flow

$590.80K

Capital Expenditure

-$4.00

Free Cash Flow

$590.79K

Cash & ST Invst.

$1.48M

Total Debt

$46.26K

Reflect Scientific Performance Analysis

Reflect Scientific annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,041,297-27.5%
20232023-12-31USD 1,080,154-47.1%
20242024-12-31USD 1,876,98173.8%
20252025-12-31USD 1,614,262-14.0%
Reflect Scientific sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3042.8%
Q42025-12-3141.7%
Q12026-03-31-30.5%
Q22026-06-305.8%
Reflect Scientific annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.00-91.0%
20232023-12-31USD -0.01N/A
20242024-12-31USD 0.00N/A
20252025-12-31USD 0.0020.0%
Reflect Scientific sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30600.0%
Q42025-12-31180.0%
Q12026-03-31-42.9%
Q22026-06-3037.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$416.24K

+48.7%

Gross Profit

$178.52K

-0.9%

Gross Margin

42.89%

N/A

Market Cap

$4.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$710.43K

N/A

Employees

6

N/A

Net Income

$92.83K

+1679.1%

EBITDA

$101.88K

+2407.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$1.48M

+13.6%

Total Debt

$46.26K

-67.2%

Accounts Receivable

$230.62K

+24.9%

Inventory

$812.20K

+13.4%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$46.26K

-51.2%

Return on Assets

12.17%

N/A

Return on Invested Capital

11.07%

N/A

Free Cash Flow

$378.12K

+11459.8%

Operating Cash Flow

$378.12K

+11459.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VLXCVeltex Corporation
$0.04+0.00%
TDSGFTelo Genomics Corp.
$0.04+0.00%
CBSCCardiac Biotech Solutions Inc.
$0.03+0.00%
LIFDLFTD Partners Inc.
$0.19+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
KORUDirexion Shares ETF Trust - Direxion Daily Msci South Korea Bull 3x Shares
$17.84-0.24%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$44.19+0.15%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$129.10-0.15%
INTCIntel
$96.69-0.07%

Questions About RSCF

What is the current price of Reflect Scientific?

Reflect Scientific is trading at $0.05 per share.

What is the 52-week range for Reflect Scientific?

Over the past 52 weeks, Reflect Scientific has traded between $0.02 and $0.07.

How much debt does Reflect Scientific have?

As of the most recent reporting period, Reflect Scientific reported total debt of $46.26K.

How much cash does Reflect Scientific have on hand?

Reflect Scientific reported $1.48M in cash and cash equivalents in its most recent financial results.

What is Reflect Scientific’s dividend yield?

Reflect Scientific does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services